🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is World Neglected Tropical Disease (#NTD) Day. MDGH is proud to be amongst the community of partners for World NTD Day. Visit worldntdday.org for more information, and visit medicinesdevelopment.com to learn more about our mission. #EndTheNeglect #beatNTDs

As a healthcare partner, MDGH recognizes World Leprosy Day, by supporting efforts to eliminate the suffering, psychosocial impact and stigmatization of this devastatingly chronic, but curable, disease. #BeatLeprosy #EndtheStigma #WorldLeprosyDay #EliminateLeprosy #beatNTDs

We’re proud to acknowledge the 6th UN International Day of Women and Girls in Science: 78% of our team at @MDGH are #WomeninSTEM, developing medicines and vaccines for people who need them most. We’re pleased to introduce you to some of our senior scientists:

“[W]e urge the world to look at how we’ve responded to #COVID19 and imagine – and fight for – a world where all disease threats are treated with urgency commensurate with the devastation that they wreak.” – Willo Brock, Andrea Lucard and Mark Sullivan ow.ly/obv950Dx9i1

Our latest newsletter is now available. Read more about latest news from MDGH: mailchi.mp/0abcf56511b2/m…

Data on our new compound #CC11050 (also known as #AMG634) on #TB published by The Aurum Institute in The Lancet (doi.org/10.1016/S2213-…) showing positive impact on FEV1.

#TB is a major cause of ill health and one of the top 10 causes of death worldwide: 2B people have latent infection and, in 2019 alone, 1.4M died. TB is a pandemic that has been with us for thousands of years and we're still fighting it. #endTB  #WorldTBDay #theclockisticking

Plus linked Comment: Moxidectin: an ally to ivermectin for treating Strongyloides stercoralis? thelancet.com/journals/lanin…

Results from a dose-ranging Phase 2a study of #moxidectin in #Strongyloides stercoralis infection in adults recently published in Lancet Infectious Diseases. #endNTDs thelancet.com/journals/lanin…

Our annual report is now published. Find out more about our accomplishments from 2020 and our development plans for #moxidectin and CC-11050. Much work remains to be done to #endNTDs and #endTB. Download here: medicinesdevelopment.com/assets/pdf/MDG…

MDGH is pleased to announce treatment of first enrollees in 3 key clinical trials of #moxidectin in #onchocerciasis co-funded by EDCTP: repeat dose implementation study; single-dose implementation safety study; pediatric dose-finding study #endNTDs. mox4oncho-multimox.net

Our Q2 2021 Newsletter is live! Read here: mailchi.mp/a947496c29ba/m…

Join MDGH at #TropMed21 virtual meeting this week, delivering 2 presentations at symposium on clin development of new treatments to eliminate onchocerciasis, and early results from open label study to find optimal dose of moxidectin in children aged 4-11. bit.ly/3DBJOMT

Mark Sullivan, Founder of MDGH has been awarded Officer of the Order of Australia (AO), one of highest civilian honours in Australia. Mark was recognised “for distinguished service to medical research, to business, and to education” Read more: urldefense.proofpoint.com/v2/url?u=https…

MDGH is proud to be a partner for #WorldNTDDay – Sunday January 30, 2022. Visit our website to learn more about our mission to develop new medicines for several of these important NTDs. medicinesdevelopment.com/our-work/pipel…

Leading 🇦🇺 voices have written to Not ScoMo calling for: 🌏$250m to COVAX to tackle global vaccine inequity 👩‍⚕️$50m to address hesitancy in our region 🦠$100m to CEPI to reduce future pandemics Open Letter - endcovidforall.com/media #EndCOVIDforAll #auspol

Vanuatu validated by World Health Organization (WHO) for eliminating trachoma as public health problem. It's the 1st country in Pacific Islands, the 4th World Health Organization (WHO) Western Pacific country and 14th country globally to achieve this milestone. Congrats to all on this great success. #Vanuatu! #beatNTDs #NTDRoadmap2030

Medicines Development for Global Health acknowledges the Australian NGO Cooperation Program and Fred Hollows for their assistance to #Vanuatu in the successful efforts to eliminate trachoma as a public health problem. trachomacoalition.org/news-blogs/van…

Medicines Development for Global Health congratulates Founder and Managing Director Mark Sullivan on being named to the 2022 PharmaVoice 100 list of top industry leaders. Read more: pharmavoice.com/news/mark-sull…

Australia’s building new partnerships to strengthen our shared regional #healthsecurity. With @APCOVE, Menzies Research & Medicines Development for Global Health, we’re supporting countries to strengthen #OneHealth monitoring, prevent outbreaks, and develop new treatments for neglected tropical diseases.